| Q48536649 | ACG Clinical Guideline: Alcoholic Liver Disease |
| Q38884700 | Acute Alcoholic Hepatitis, the Clinical Aspects. |
| Q82511125 | Advances in Alcoholic Liver Disease |
| Q35163801 | Advances in alcoholic liver disease |
| Q36269638 | Advances in alcoholic liver disease: An update on alcoholic hepatitis |
| Q52412913 | Alcoholic Hepatitis. |
| Q42023633 | Alcoholic Liver Disease: Pathogenesis and Current Management |
| Q27000153 | Alcoholic and non-alcoholic steatohepatitis |
| Q53580504 | Alcoholic hepatitis: Continued drinking and the mourning after. |
| Q38209601 | Alcoholic hepatitis: current management |
| Q37834051 | Alcoholic liver disease and malnutrition |
| Q51764048 | Alcoholic liver disease. |
| Q34255479 | Alcoholic liver disease: treatment |
| Q37801097 | Alcoholic steatohepatitis |
| Q36750275 | Alcoholic steatohepatitis: management and prognosis |
| Q37635136 | Alcoholic, Nonalcoholic, and Toxicant-Associated Steatohepatitis: Mechanistic Similarities and Differences |
| Q24244334 | Anabolic-androgenic steroids for alcoholic liver disease |
| Q24250225 | Anabolic-androgenic steroids for alcoholic liver disease |
| Q48944904 | Correction of all-trans retinoic acid deficiency in alcoholic cirrhosis lessens the excessive inflammatory monocyte response: a translational study. |
| Q53651120 | Corticosteroid plus pentoxifylline is not better than corticosteroid alone for improving survival in severe alcoholic hepatitis (COPE trial). |
| Q26746544 | Current Management of Alcoholic Hepatitis and Future Therapies |
| Q36655119 | Current concepts and controversies in the treatment of alcoholic hepatitis |
| Q34197895 | Definition, epidemiology and magnitude of alcoholic hepatitis |
| Q41999437 | Development, Prevention, and Treatment of Alcohol-Induced Organ Injury: The Role of Nutrition |
| Q91954715 | Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases |
| Q36038296 | Diagnosis and Treatment of Alcoholic Hepatitis: A Systematic Review |
| Q37811070 | Diagnosis and management of alcoholic liver disease |
| Q35944561 | Diagnosis and treatment of alcoholic liver disease and its complications. |
| Q30431186 | Diagnosis of alcoholic liver disease |
| Q98613142 | Effect of zinc treatment on clinical outcomes in patients with liver cirrhosis: A systematic review and meta-analysis |
| Q92814833 | Essential Amino Acid Supplement Lowers Intrahepatic Lipid despite Excess Alcohol Consumption |
| Q36146071 | Ethanol and High Cholesterol Diet Causes Severe Steatohepatitis and Early Liver Fibrosis in Mice |
| Q36478110 | Factors Associated With Protein-energy Malnutrition in Chronic Liver Disease: Analysis Using Indirect Calorimetry |
| Q37078455 | Folate, alcohol, and liver disease |
| Q92967670 | Glucocorticosteroids for people with alcoholic hepatitis |
| Q47548940 | Glucocorticosteroids for people with alcoholic hepatitis. |
| Q33887403 | Hyperhomocysteinemia in chronic alcoholism: relations to folic acid and vitamins B(6) and B(12) status |
| Q51303871 | Identifying in-patient costs attributable to the clinical sequelae and comorbidities of alcoholic liver disease in a national hospital database. |
| Q36372382 | Interactions of ethanol and folate deficiency in development of alcoholic liver disease in the micropig. |
| Q37229858 | KASL clinical practice guidelines: management of alcoholic liver disease |
| Q38992635 | Malnutrition and Nutritional Support in Alcoholic Liver Disease: a Review. |
| Q93140528 | Management of patients with moderate alcoholic liver disease |
| Q38058001 | Neurological complications post-liver transplantation: impact of nutritional status. |
| Q38884714 | Nutrition and Alcoholic Liver Disease: Effects of Alcoholism on Nutrition, Effects of Nutrition on Alcoholic Liver Disease, and Nutritional Therapies for Alcoholic Liver Disease |
| Q41069360 | Nutrition impact symptoms, handgrip strength and nutritional risk in hospitalized patients with gastroenterological and liver diseases. |
| Q36506081 | Nutrition in alcoholic liver disease |
| Q38371556 | Nutrition in the management of cirrhosis and its neurological complications. |
| Q73795242 | Nutritional assessment in alcoholic patients. Its relationship with alcoholic intake, feeding habits, organic complications and social problems |
| Q44506515 | Nutritional intake of hazardous drinkers and dependent alcoholics in the UK. |
| Q73438150 | Nutritional status of substance abusers with mandible fractures |
| Q38341888 | Nutritional therapy in cirrhosis or alcoholic hepatitis: a systematic review and meta-analysis |
| Q37696026 | Pathophysiology and Management of Alcoholic Liver Disease: Update 2016. |
| Q92582630 | Patterns of alcohol consumption and nutrition intake in patients with alcoholic liver disease and alcoholic pancreatitis in North Indian men |
| Q42946735 | Pentoxifylline Plus Prednisolone versus Pentoxifylline Only for Severe Alcoholic Hepatitis: A Randomized Controlled Clinical Trial |
| Q39047901 | Pharmacologic Treatment of Alcoholic Hepatitis: Examining Outcomes Based on Disease Severity Stratification. |
| Q38681092 | Pharmacotherapy of alcoholic liver disease in clinical practice |
| Q37421502 | Practical Concerns and Controversies in the Management of Alcoholic Hepatitis |
| Q38203313 | Prognosis and treatment of patients with acute alcoholic hepatitis |
| Q35944548 | Relationships between nutrition, alcohol use, and liver disease. |
| Q28087493 | Reprint of: Nutrition in the Management of Cirrhosis and its Neurological Complications |
| Q52206400 | Resting energy expenditure should be measured in patients with cirrhosis, not predicted. |
| Q36609894 | Review article: alcoholic liver disease--pathophysiological aspects and risk factors. |
| Q55396095 | Role of Nutrition in Alcoholic Liver Disease: Summary of the Symposium at the ESBRA 2017 Congress. |
| Q42158270 | Role of nutrition in the management of hepatic encephalopathy in end-stage liver failure. |
| Q45347865 | Roles of gender, obesity, and lifestyle-related diseases in alcoholic liver disease: Obesity does not influence the severity of alcoholic liver disease |
| Q38756962 | Sarcopenia in Alcoholic Liver Disease: Clinical and Molecular Advances. |
| Q35073002 | Symptoms and signs of acute alcoholic hepatitis |
| Q46847997 | The Challenges of Nutritional Assessment in Cirrhosis |
| Q36918881 | The role of nutritional therapy in alcoholic liver disease. |
| Q34554574 | The use of selected nutrition supplements and complementary and alternative medicine in liver disease |
| Q37821008 | Therapeutic effects of anabolic androgenic steroids on chronic diseases associated with muscle wasting |
| Q94402007 | Tratamiento de la hepatitis alcohólica |
| Q93140541 | Treatment of alcoholic hepatitis |
| Q82688643 | Treatment of alcoholic liver disease |
| Q34565692 | Treatment of alcoholic liver disease |
| Q42695159 | Treatment options for alcoholic and non-alcoholic fatty liver disease: A review |
| Q95443981 | [Guidelines for specialized nutritional and metabolic support in the critically-ill patient. Update. Consensus of the Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE): |
| Q73878796 | [Prevalence of malnutrition and morphofunctional alterations of the pancreas in asymptomatic chronic alcoholic patients] |